148 related articles for article (PubMed ID: 19687192)
1. Homeopathic Individualized Q-Potencies versus Fluoxetine for Moderate to Severe Depression: Double-Blind, Randomized Non-Inferiority Trial.
Adler UC; Paiva NM; Cesar AT; Adler MS; Molina A; Padula AE; Calil HM
Evid Based Complement Alternat Med; 2011; 2011():520182. PubMed ID: 19687192
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of individualized homeopathic treatment and fluoxetine for moderate to severe depression in peri- and postmenopausal women (HOMDEP-MENOP): study protocol for a randomized, double-dummy, double-blind, placebo-controlled trial.
Macías-Cortés Edel C; Aguilar-Faisal L; Asbun-Bojalil J
Trials; 2013 Apr; 14():105. PubMed ID: 23782520
[TBL] [Abstract][Full Text] [Related]
3. Individualized homeopathic treatment and fluoxetine for moderate to severe depression in peri- and postmenopausal women (HOMDEP-MENOP study): a randomized, double-dummy, double-blind, placebo-controlled trial.
Macías-Cortés Edel C; Llanes-González L; Aguilar-Faisal L; Asbun-Bojalil J
PLoS One; 2015; 10(3):e0118440. PubMed ID: 25768800
[TBL] [Abstract][Full Text] [Related]
4. Homeopathy for depression--DEP-HOM: study protocol for a randomized, partially double-blind, placebo controlled, four armed study.
Adler UC; Krüger S; Teut M; Lüdtke R; Bartsch I; Schützler L; Melcher F; Willich SN; Linde K; Witt CM
Trials; 2011 Feb; 12():43. PubMed ID: 21320338
[TBL] [Abstract][Full Text] [Related]
5. Is metabolic dysregulation associated with antidepressant response in depressed women in climacteric treated with individualized homeopathic medicines or fluoxetine? The HOMDEP-MENOP Study.
Macías-Cortés ED; Llanes-González L; Aguilar-Faisal L; Asbun-Bojalil J
Homeopathy; 2017 Feb; 106(1):3-10. PubMed ID: 28325221
[TBL] [Abstract][Full Text] [Related]
6. Homeopathy for depression: a randomized, partially double-blind, placebo-controlled, four-armed study (DEP-HOM).
Adler UC; Krüger S; Teut M; Lüdtke R; Schützler L; Martins F; Willich SN; Linde K; Witt CM
PLoS One; 2013; 8(9):e74537. PubMed ID: 24086352
[TBL] [Abstract][Full Text] [Related]
7. Double-blind evaluation of homeopathy on cocaine craving: a randomized controlled pilot study.
Adler UC; Acorinte AC; Calzavara FO; da Silva AA; de Toledo Cesar A; Adler MS; Martinez EZ; Galduróz JCF
J Integr Med; 2018 May; 16(3):178-184. PubMed ID: 29625852
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
9. Response to Individualized Homeopathic Treatment for Depression in Climacteric Women with History of Domestic Violence, Marital Dissatisfaction or Sexual Abuse: Results from the HOMDEP-MENOP Study.
Macías-Cortés EDC; Llanes-González L; Aguilar-Faisal L; Asbun-Bojalil J
Homeopathy; 2018 Aug; 107(3):202-208. PubMed ID: 29871025
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial.
Lam RW; Levitt AJ; Levitan RD; Michalak EE; Cheung AH; Morehouse R; Ramasubbu R; Yatham LN; Tam EM
JAMA Psychiatry; 2016 Jan; 73(1):56-63. PubMed ID: 26580307
[TBL] [Abstract][Full Text] [Related]
11. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine.
Szegedi A; Kohnen R; Dienel A; Kieser M
BMJ; 2005 Mar; 330(7490):503. PubMed ID: 15708844
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
Nemeroff CB; Thase ME;
J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
[TBL] [Abstract][Full Text] [Related]
13. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study.
Wiart L; Petit H; Joseph PA; Mazaux JM; Barat M
Stroke; 2000 Aug; 31(8):1829-32. PubMed ID: 10926942
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression.
Rudolph RL; Feiger AD
J Affect Disord; 1999 Dec; 56(2-3):171-81. PubMed ID: 10701474
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
[TBL] [Abstract][Full Text] [Related]
17. Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression: a randomized double-blind trial in a Brazilian sample.
Moreno RA; Teng CT; Almeida KM; Tavares Junior H
Braz J Psychiatry; 2006 Mar; 28(1):29-32. PubMed ID: 16612487
[TBL] [Abstract][Full Text] [Related]
18. New statistical proposals to evaluate the benefit/risk ratio of long-term treatment of depression: application to a one-year double-blind study comparing medifoxamine with fluoxetine.
Lehert P; Poirier-Littre MF; Pringuey D; Galinowski A
Clin Drug Investig; 1998; 15(4):285-95. PubMed ID: 18370483
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.
Emslie GJ; Rush AJ; Weinberg WA; Kowatch RA; Hughes CW; Carmody T; Rintelmann J
Arch Gen Psychiatry; 1997 Nov; 54(11):1031-7. PubMed ID: 9366660
[TBL] [Abstract][Full Text] [Related]
20. Hypericum extract LI 160 and fluoxetine in mild to moderate depression: a randomized, placebo-controlled multi-center study in outpatients.
Bjerkenstedt L; Edman GV; Alken RG; Mannel M
Eur Arch Psychiatry Clin Neurosci; 2005 Feb; 255(1):40-7. PubMed ID: 15538592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
